Join us   Log in   editor@ijcicr.com  

INTERNATIONAL JOURNAL OF CLINICAL INVESTIGATION AND CASE REPORTS - Volume 2, Issue 1, (Jan-Mar)

Pages: 13-19

Date of Publication: 31-Mar-2023


Print Article   Download XML  Download PDF

Clinical Trials Trends of 2023 Year and Visionary to the Future

Author: Svyatoslav S. Milovanov* (USA)

Category: Clinical Trials

Abstract:

Introduction: The importance of studying historical changes in the development of human activity is substantiated by the need to systematize such changes and the possibility of predicting them. Historical changes are extended in time and do not have clear boundaries, requiring greater involvement in their study and the prerequisites for their appearance. Clinical research is more than just the practical application of medical changes and discoveries. They make changes in medical practice but are subject to change. Changes in the clinical research industry are tendentious and develop gradually, requiring study and forecasting. According to the generally accepted temporal gradation of the forecast, there is an operational forecast of up to one month, a short-term forecast of up to one year, a medium-term forecast of up to five years, a long-term forecast of up to 20 years and a long-term forecast over long-term, and a short-term forecast is common in the clinical research industry. We analyzed publications in open sources from 1930 to 2023 by keywords in the Russian-language literature trends in the clinical trial industry and the English-language literature trends in the clinical trial industry.

Discussion and Conclusion: Trends in the development of clinical trials until the end of 2023 can be divided into two groups, those related to changes in the conduct of clinical trials and changes in the products of clinical trials in nosologies. If in the first group, the trends remain similar to 2022, the ongoing digitalization of operations, the shift of centralized research towards decentralization, and the shift in protocol design towards patient-centricity, then in the second group, the number of expected drugs has decreased, and there is a shift of drugs towards biologics and gene therapy drugs.

Keywords: Clinical Trials Tendencies , Real World Data , Decentralized Trials, Hybrid Clinical Trials, Artificial Intelligence in Clinical Trials

DOI: 10.55828/ijcicr-21-04

DOI URL: http://dx.doi.org/10.55828/ijcicr-21-04

References:

  1. Bull JP. The historical development of clinical therapeutic trials. J Chronic Dis. 1959;10(3):218-248.
  2. Lilienfeld AM. Ceteris paribus: the evolution of the clinical trial. Bull Hist Med. 1982;56(1):1-18.
  3. Koterov AN, Tikhonova OA, Ushenkova LN, et al. History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2021;14(1):72-98.
  4. Langton J. A discussion on the treatment of hernia in children. Brit Med J. 1896;2(73):470-472.
  5. https://ru.wikipedia.org/wiki/????????????_??????/
  6. Milovanov Svyatoslav. Principal investigators and site in the challenges of clinical trials recruitment and contemporary tendencies. Clin Res Clin Trials. 2022;6(1):1-5.
  7. Kozlov I.G. Monoclonal antibodies: a new era in pharmacology and therapy. Medical business. 2006; 1:26-29.
  8. Xavier Anguela M, Katherine A. High entering the modern era of gene therapy. Annu Rev Med. 2019;70(1):273-288.
  9. Lazarus A. The changing landscape of pharmaceutical medicine. Physician Exec. 2004;30(4):40-43.
  10. DeSantis S. Biotech changing the clinical trial landscape. The CenterWatch Monthly.2005;12(12):11-16.
  11. Munroe JB. A coalition to drive personalized medicine forward. Per Med. 2004;1(1):9-13.
  12. Hekmat R, Nawshin K, Courtney V, et al. Accelerating clinical trial design and operations. App Clin Trials. 2021;30(3):25-29.
  13. Blake Adams. Decentralized clinical trials. JACC Basic Transl Sci. 2022; 6(4): 384-387.
  14. Bob TL, Bobby D, Gospodarowicz M et al. Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition. Nat Med. 2022;28(4):620-626.
  15. Sinha Abhishek. The Future of pharma lies in gaming technologies. Life Sci Lead. 2022.
  16. Koski G, Kennedy L, Tobin MF, et al. Accreditation of clinical research sites moving forward. N Engl J Med. 2018;379(5):405-407.
  17. Dario Sabaghi. Pfizer bets on medical cannabis with $6.7 billion acquisition. https://www.forbes.com/sites/dariosabaghi/2021/12/20/pfizer-to-enter-the-medical-cannabis-industry-with-67-billion-acquisition/?sh=75cc89ec6072. Accessed 12 March 2023.
  18. FDA. Use of electronic informed consent in clinical investigations – questions and answers. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-electronic-informed-consent-clinical-investigations-questions-and-answers. Accessed 12 March 2023.
  19. FDA. Drug Trials Snapshots Summary Report 2020. https://www.fda.gov/media/145718/download. Accessed 12 March 2023.
  20. https://docusign.com/. Accessed 12 March 2023.
  21. https://popsicube.com/project/popsipay/. Accessed 12 March 2023.
  22. https://www.startus-insights.com/innovators-guide/clinical-trial-trends/. Accessed 12 March 2023.
  23. Clinical Leader. What trends will have the biggest impact on clinical trials in 2023? https://www9.clinicalleader.com/cl-clinical-trends-2023-special-report/?utm_source=linkedin&utm_medium=social&utm_campaign=clncl-social-02-13-2023. Accessed 12 March 2023.
  24. Clinical Leader. Trends impacting clinical research. Source: Advarra https://www.clinicalleader.com/doc/trends-impacting-clinical-research-0001. Accessed 12 March 2023.
  25. Petrini C, Mannelli C, Riva L, et al. Decentralized Clinical Trials (DCTs): A few ethical considerations. Front Public Health. 2022; 10:1081150.
  26. Alsumidaie M. SCOPE 2023: Adapting to the changing landscape of clinical trials and the biopharmaceutical industry. 2023. https://www.appliedclinicaltrialsonline.com/view/scope-2023-adapting-to-the-changing-landscape-of-clinical-trials-and-the-biopharmaceutical-industry. Accessed 12 March 2023 year.
  27. Grady C, Edgerly M. Science, technology, and innovation: nursing responsibilities in clinical research. Nurs Clin North Am. 2009;44(4):471-81. doi: 10.1016/j.cnur.2009.07.011.
  28. Revolutionizing Clinical Trials: The Vital Role of Research Nurses in Decentralized Trials https://wrenhc.com/news/the-role-of-research-nurses-in-decentralized-clinical-trials/Accessed. 12 March 2023.
  29. US FDA. https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence. Accessed 12 March 2023.
  30. Mukhina SM, Baranova MI, Yu BE. HARPER—protocol template for real clinical practice studies to evaluating efficacy. Real Wor Data Evid. 2022;2(4):17-25.
  31. Milovanov S. Predicting of enrollment as a part of risk-based management of clinical trials. Int Clin Img and Med Rew. 2022;3(2):1113.
  32. Science Insider. FDA no longer needs to require animal tests before human drug trials. https://www.science.org/content/article/fda-no-longer-needs-require-animal-tests-human-drug-trials. Accessed 12 March 2023.
  33. Financial Force. A Connected clinical trial experience - end fragmented data & elevate success. https://video.financialforce.com/watch/CxJrESDy2wFR1J6Nd1pF1e. Accessed 12 March 2023.
  34. EurekAlert. Insilico medicine announces positive topline results of the New Zealand Phase I trial of INS018_055, an AI-designed drug for an AI-discovered target. https://www.eurekalert.org/news-releases/976036. Accessed 12 March 2023.
  35. Karan S, Shekoofeh A, Tao T, at el. Large Language Models Encode Clinical Knowledge. Arxiv. 2022.
  36. Conews. "Father of the Internet" called for an end to investment in artificial intelligence. https://www.cnews.ru/news/top/2023-02-17_otets_interneta_predostereg Accessed 12 March 2023.
  37. PMC. Personalized Medicine at FDA. The Scope & Significance of Progress in 2021. https://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/Personalized_Medicine_at_FDA_The_Scope_Significance_of_Progress_in_2021.pdf. Accessed 12 March 2023.
  38. Wikipedia. Bayer’s Theorem. https://ru.wikipedia.org/wiki/???????_??????. Accessed 12 March 2023.
  39. Birckhead B, Khalil C, Liu X, et al. Recommendations for methodology of virtual reality clinical trials in health care by an international working group: iterative study. JMIR Ment Health. 2019;6(1):e11973.
  40. Medvir. Join us to create the future of medical extended reality. https://medvr.io/. Accessed 12 March 2023.
  41. Federal Register. https://www.federalregister.gov/documents/search?conditions%5Bpublication_date%5D%5Bis%5D=2022-09-28&conditions%5Btype%5D%5B%5D=PRORULE. Accessed 12 March 2023.
  42. Ayalew K, et al. The United States food and drug administration’s innovative alternative tools to evaluate good clinical practice during the COVID-19 public health emergency. J Soc Clin Data Man. 2022; 2(2):1-7.
  43. Generium. Pharmacy chain Walgreens will launch its clinical trial program. https://pharmvestnik.ru/content/news/Aptechnaya-set-Walgreens-zapustit-svou-programmu-klinicheskih-ispytanii.html?utm_source=letternews&utm_medium=letter&utm_campaign=daily. Accessed 12 March 2023.
  44. Chemrar. List of potential blockbuster drugs of 2023 compiled. https://chemrar.ru/sostavlen-spisok-potencialnyx-lekarstv-blokbasterov-2023-goda/?utm_source=telegram&utm_medium=cpc&utm_campaign=20-02-2023-1. Accessed 12 March 2023.
  45. Clarivate. Transformative intelligence for a healthier tomorrow. https://clarivate.com/wp-content/uploads/dlm_uploads/2022/12/J0541_Drugs-to-Watch_Report_2023_V8.2.pdf. Accessed 12 March 2023.
  46. PMC. A strategic plan for advancing personalized medicine in 2023. https://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/strategic_plan1.pdf. Accessed 12 March 2023.
  47. PMC. Personalized medicine at FDA. The Scope & Significance of Progress in 2022. https://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/report.pdf. Accessed 12 March 2023.
  48. PMC. Moving beyond population averages. https://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/PMC_Moving_Beyond_Population_Averages_A_Patient-Centered_Research_Agenda_Advancing_Personalized_Medicine1.pdf. Accessed 12 March 2023.
  49. Nature review drug discovery. 2022 FDA approvals. https://www.nature.com/articles/d41573-023-00001-3. Accessed 12 March 2023.
  50. Adams B, Zoey B, Kevin D. Top 10 most anticipated drug launches of 2023. https://www.fiercepharma.com/marketing/top-10-most-anticipated-drug-launches-2023. Accessed 12 March 2023.
  51. Brian B. 25 potential blockbusters to keep an eye on in 2023. https://www.drugdiscoverytrends.com/25-potential-blockbusters-to-keep-an-eye-on-in-2023/. Accessed 12 March 2023.
  52. IQVIA. Global Trends in R&D 2023 Activity, Productivity, and Enablers. https://www.iqvia.com/insights/the-iqvia-institute/reports/global-trends-in-r-and-d-2023. Accessed 12 March 2023.
  53. MIT Technology Review. 2022’s seismic shift in US tech policy will change how we innovate. https://www.technologyreview.com/2023/01/09/1064735/us-tech-policy-changing-innovation/. Accessed 12 March 2023.
  54. Health Affairs Forefront. Antimicrobial Resistance: A major threat to the promise of healthy aging. https://www.healthaffairs.org/content/forefront/antimicrobial-resistance-major-threat-promise-healthy-aging. Accessed 12 March 2023.
  55. Milovanov SS. Predicting of patient’s enrollment to multicentral international clinical trials of II–III phase. Int J Clin Trials. 2021;8(1):73-78.
  56. Feirce Biotech. 2022's 10 top clinical trial flops. https://www.fiercebiotech.com/special-reports/2022s-top-10-clinical-trial-flops. Accessed 12 March 2023.
  57. Drug discovery & development. The top 10 pharma M&A deals of 2022. https://www.drugdiscoverytrends.com/the-top-10-pharma-ma-deals-of-2022/. Accessed 12 March 2023.
  58. Bridge T, Wegmann U, Crack JC et al. Site-specific encoding of photoactivity and photo reactivity into antibody fragments. Nat Chem Biol. 2023.
  59. University of East Anglia. Scientists make breakthrough for 'next generation' cancer treatment. https://medicalxpress.com/news/2023-02-scientists-breakthrough-generation-cancer-treatment.html. Accessed 12 March 2023.